Cardiac Pacemaker, Artificial
10
0
2
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
10.0%
1 terminated out of 10 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
86%
6 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (10)
BIO|MASTER.CSP Study
Aveir DR i2i Study
Patient Preferences for Leadless Pacemakers
Imaging Study of Lead Implant for His Bundle Pacing
Clinical Investigation Plan for the AVOPT Data Collection Clinical Study
Advisa MRI Clinical Study
The Potential Interference of Magnets From a Surgical Magnetic Drape With Cardiac Pacemakers
Optimize RV Selective Site Pacing Clinical Trial
Actions Elicited by In-hospital Follow-up of Cardiac Devices
Optivol Diagnostic Data for Discharge in Heart Failure